Patient-Derived Xenograft (PDX) in Humanized Mice

PDX Studies

• Partnership with Champions Oncology: TransCure becomes the European hub and operational center
• Large cohort (> 1,000 patient tumors) of TumorGraft®
• Multiple tumor types
• Fully characterized and searchable (medical history, genetic, mutations, growth, in vivo drug responses)
• Faithful reconstitution of patient tumor biology in hu-mouse models